{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T15:06:58Z","timestamp":1789225618335,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"DOI":"10.1007\/s00431-026-07331-5","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T23:18:12Z","timestamp":1786403892000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mental health, sleep, and quality of life following CFTR modulator therapy: a longitudinal study of children with cystic fibrosis and caregivers"],"prefix":"10.1007","volume":"185","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1316-9545","authenticated-orcid":false,"given":"Hande","family":"Yeti\u015fgin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I\u015f\u0131l","family":"Bilgi\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meltem","family":"K\u00fcrt\u00fcl \u00c7akar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gamze","family":"Akca Din\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayy\u00fcce","family":"\u00dcnl\u00fc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c7elebi","family":"Y\u0131ld\u0131r\u0131m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ay\u00e7a","family":"La\u00e7in Tekin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sat\u0131","family":"\u00d6zkan Tabak\u00e7\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u015eule Selin","family":"Akyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6k\u00e7en Dil\u015fa","family":"Tu\u011fcu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilber","family":"Ademhan Tural","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanem","family":"Ery\u0131lmaz Polat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fclser","family":"\u015eenses Din\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esra","family":"\u00c7\u00f6p","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fczin","family":"Cinel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,11]]},"reference":[{"issue":"9","key":"7331_CR1","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1007\/s00431-021-04168-y","volume":"180","author":"MC Bierlaagh","year":"2021","unstructured":"Bierlaagh MC, Muilwijk D, Beekman JM, van der Ent CK (2021) A new era for people with cystic fibrosis. Eur J Pediatr 180(9):2731\u20132739","journal-title":"Eur J Pediatr"},{"issue":"10","key":"7331_CR2","doi-asserted-by":"publisher","first-page":"496","DOI":"10.5694\/mja2.52119","volume":"219","author":"S Kumar","year":"2023","unstructured":"Kumar S, Soldatos G, Teede HJ, Pallin M (2023) Effects of modulator therapies on endocrine complications in adults with cystic fibrosis: a narrative review. Med J Aust 219(10):496\u2013502","journal-title":"Med J Aust"},{"issue":"9","key":"7331_CR3","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1002\/ppul.26535","volume":"58","author":"S Uytun","year":"2023","unstructured":"Uytun S, Cinel G, Ery\u0131lmaz Polat S, \u00d6zkan Tabak\u00e7\u0131 S, Kiper N, Yal\u00e7\u0131n E et al (2023) Patients with cystic fibrosis who could not receive the CFTR modulator treatment: what did they lose in 1 year? Pediatr Pulmonol 58(9):2505\u20132512","journal-title":"Pediatr Pulmonol"},{"key":"7331_CR4","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1080\/17476348.2021.1855980","volume":"15","author":"PG Middleton","year":"2021","unstructured":"Middleton PG, Taylor-Cousar JL (2021) Development of elexacaftor\u2013tezacaftor\u2013ivacaftor: highly effective CFTR modulation for the majority of people with cystic fibrosis. Expert Rev Respir Med 15:723\u2013735","journal-title":"Expert Rev Respir Med"},{"issue":"7","key":"7331_CR5","doi-asserted-by":"publisher","first-page":"e01172","DOI":"10.1002\/rcr2.1172","volume":"11","author":"PG Middleton","year":"2023","unstructured":"Middleton PG, Simmonds NJ (2023) Cystic fibrosis modulator therapy can reverse cystic bronchiectasis. Respirol Case Rep 11(7):e01172","journal-title":"Respirol Case Rep"},{"issue":"6","key":"7331_CR6","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1097\/MCP.0000000000001014","volume":"29","author":"MB VanElzakker","year":"2023","unstructured":"VanElzakker MB, Tillman EM, Yonker LM, Ratai EM, Georgiopoulos AM (2023) Neuropsychiatric adverse effects from CFTR modulators deserve a serious research effort. Curr Opin Pulm Med 29(6):603\u2013609","journal-title":"Curr Opin Pulm Med"},{"issue":"7","key":"7331_CR7","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1002\/ppul.26412","volume":"58","author":"E Baroud","year":"2023","unstructured":"Baroud E, Chaudhary N, Georgiopoulos AM (2023) Management of neuropsychiatric symptoms in adults treated with elexacaftor\/tezacaftor\/ivacaftor. Pediatr Pulmonol 58(7):1920\u20131930","journal-title":"Pediatr Pulmonol"},{"issue":"10","key":"7331_CR8","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1002\/ppul.27100","volume":"59","author":"H Pham","year":"2024","unstructured":"Pham H, Vandeleur M, Mainzer RM, Ranganathan S (2024) Mental health, sleep, and respiratory health after initiating ETI in children with CF. Pediatr Pulmonol 59(10):2606\u20132613","journal-title":"Pediatr Pulmonol"},{"key":"7331_CR9","doi-asserted-by":"publisher","first-page":"175346662211442","DOI":"10.1177\/17534666221144211","volume":"16","author":"L Zhang","year":"2022","unstructured":"Zhang L, Albon D, Jones M, Bruschwein H (2022) Impact of ETI on depression and anxiety in cystic fibrosis. Ther Adv Respir Dis 16:17534666221144212","journal-title":"Ther Adv Respir Dis"},{"issue":"6","key":"7331_CR10","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.jcf.2022.05.001","volume":"21","author":"G Spoletini","year":"2022","unstructured":"Spoletini G, Gillgrass L, Pollard K et al (2022) Dose adjustments of elexacaftor\/tezacaftor\/ivacaftor in response to mental health side effects in adults with cystic fibrosis. J Cyst Fibros 21(6):1061\u20131065","journal-title":"J Cyst Fibros"},{"issue":"1","key":"7331_CR11","first-page":"82","volume":"29","author":"SR Duehlmeyer","year":"2024","unstructured":"Duehlmeyer SR, Elson EC, Oermann CM (2024) New tic disorder in a child treated with ETI. J Pediatr Pharmacol Ther 29(1):82\u201384","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"3","key":"7331_CR12","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.jcf.2023.01.015","volume":"22","author":"M Arslan","year":"2023","unstructured":"Arslan M, Chalmers S, Rentfrow K et al (2023) Suicide attempts in adolescents with cystic fibrosis on Elexacaftor\/Tezacaftor\/Ivacaftor therapy. J Cyst Fibros 22(3):427\u2013430","journal-title":"J Cyst Fibros"},{"issue":"3","key":"7331_CR13","doi-asserted-by":"publisher","first-page":"e71037","DOI":"10.1002\/ppul.71037","volume":"60","author":"B Uzunoglu","year":"2025","unstructured":"Uzunoglu B, Selcuk Balci M, Kalyoncu M et al (2025) ETI accessibility and mental health. Pediatr Pulmonol 60(3):e71037","journal-title":"Pediatr Pulmonol"},{"key":"7331_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2024.07.008","author":"M Nguyen","year":"2024","unstructured":"Nguyen M, MacDiarmid P, Tanzler A et al (2024) Impact of ETI on anxiety and depression in adults with CF. J Cyst Fibros. https:\/\/doi.org\/10.1016\/j.jcf.2024.07.008","journal-title":"J Cyst Fibros"},{"issue":"1","key":"7331_CR15","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s41687-025-00879-0","volume":"9","author":"F Buniotto","year":"2025","unstructured":"Buniotto F, Tridello G, De Scolari A et al (2025) Improved quality of life in cystic fibrosis patients observed up to 36 months after starting elexacaftor\/tezacaftor\/ivacaftor treatment. J Patient Rep Outcomes 9(1):48","journal-title":"J Patient Rep Outcomes"},{"issue":"1","key":"7331_CR16","doi-asserted-by":"publisher","first-page":"e71461","DOI":"10.1002\/ppul.71461","volume":"61","author":"S K\u00fcmmerli","year":"2026","unstructured":"K\u00fcmmerli S, Elviro CF, Regamey N et al (2026) Impact of elexacaftor\u2013tezacaftor\u2013ivacaftor on quality of life in children with cystic fibrosis. Pediatr Pulmonol 61(1):e71461","journal-title":"Pediatr Pulmonol"},{"key":"7331_CR17","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1007\/s00431-026-07130-y","volume":"185","author":"H Yeti\u015fgin","year":"2026","unstructured":"Yeti\u015fgin H, Akyan Soyda\u015f \u015eS, \u00d6zkan Tabak\u00e7\u0131 S et al (2026) Early effect of CFTR modulators on the mental health of patients with cystic fibrosis and parents. Eur J Pediatr 185:464","journal-title":"Eur J Pediatr"},{"issue":"6","key":"7331_CR18","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","volume":"14","author":"MW Johns","year":"1991","unstructured":"Johns MW (1991) A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14(6):540\u2013545","journal-title":"Sleep"},{"issue":"3","key":"7331_CR19","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1080\/02739615.2021.2000413","volume":"51","author":"SD Uygun","year":"2022","unstructured":"Uygun SD, Bilbay NT (2022) Psychometric evaluation of the Turkish adaptation of the Epworth sleepiness scale for children and adolescents. Child Health Care 51(3):235\u2013249","journal-title":"Child Health Care"},{"key":"7331_CR20","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1093\/geront\/20.6.649","volume":"20","author":"SH Zarit","year":"1980","unstructured":"Zarit SH, Reever KE, Bach-Peterson J (1980) Relatives of the impaired elderly: correlates of feelings of burden. Gerontologist 20:649\u2013655","journal-title":"Gerontologist"},{"issue":"4","key":"7331_CR21","first-page":"85","volume":"11","author":"FH \u0130nci","year":"2008","unstructured":"\u0130nci FH, Erdem M (2008) Bak\u0131m verme y\u00fck\u00fc \u00f6l\u00e7e\u011finin T\u00fcrk\u00e7eye uyarlanmas\u0131, ge\u00e7erlilik ve g\u00fcvenirli\u011fi. Atat\u00fcrk \u00dcniversitesi Hem\u015firelik Y\u00fcksekokulu Dergisi 11(4):85\u201395","journal-title":"Atat\u00fcrk \u00dcniversitesi Hem\u015firelik Y\u00fcksekokulu Dergisi"},{"key":"7331_CR22","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1136\/thoraxjnl-2014-205983","volume":"69","author":"AL Quittner","year":"2014","unstructured":"Quittner AL, Goldbeck L, Abbott J et al (2014) Prevalence of depression and anxiety in patients with CF and parent caregivers: results of The International Depression Epidemiological Study across nine countries. Thorax 69:1090\u20131097","journal-title":"Thorax"},{"key":"7331_CR23","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1002\/ppul.21423","volume":"46","author":"T Besier","year":"2011","unstructured":"Besier T, Born A, Henrich G et al (2011) Anxiety, depression, and life satisfaction in parents caring for children with CF. Pediatr Pulmonol 46:672\u2013682","journal-title":"Pediatr Pulmonol"},{"issue":"12","key":"7331_CR24","doi-asserted-by":"publisher","first-page":"3174","DOI":"10.1002\/ppul.26116","volume":"57","author":"BC Lyman","year":"2022","unstructured":"Lyman BC, Seay J, Contreary C et al (2022) Elexacaftor-tezacaftor-ivacaftor overdose in an adolescent female with CF. Pediatr Pulmonol 57(12):3174\u20133176","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"7331_CR25","doi-asserted-by":"publisher","first-page":"e27393","DOI":"10.1002\/ppul.27393","volume":"60","author":"K Pasley","year":"2025","unstructured":"Pasley K, Eisner M, Sliemers S et al (2025) Mental Health of Pediatric Patients with CF after 18 Months on ETI Therapy. Pediatr Pulmonol 60(1):e27393","journal-title":"Pediatr Pulmonol"},{"key":"7331_CR26","doi-asserted-by":"publisher","first-page":"1179208","DOI":"10.3389\/fphar.2023.1179208","volume":"14","author":"L Piehler","year":"2023","unstructured":"Piehler L, Thalemann R, Lehmann C et al (2023) Effects of ETI on mental health in CF. Front Pharmacol 14:1179208","journal-title":"Front Pharmacol"},{"issue":"4","key":"7331_CR27","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.jcf.2024.06.010","volume":"24","author":"AD Van Citters","year":"2025","unstructured":"Van Citters AD, Aliaj E, Alvarez JA et al (2025) Wellness in the modulator era: An observational study of the impact of CFTR modulator therapy on the well-being of people with CF. J Cyst Fibros 24(4):642\u2013651","journal-title":"J Cyst Fibros"},{"key":"7331_CR28","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.202501-103OC","author":"JE Pittman","year":"2025","unstructured":"Pittman JE, Morgan S, McCreary M et al (2025) Clinical effectiveness of ETI in children aged 6\u201311 years. Ann Am Thorac Soc. https:\/\/doi.org\/10.1513\/AnnalsATS.202501-103OC","journal-title":"Ann Am Thorac Soc"},{"key":"7331_CR29","doi-asserted-by":"publisher","first-page":"7612","DOI":"10.3390\/jcm12247612","volume":"12","author":"M Cohen-Cymberknoh","year":"2023","unstructured":"Cohen-Cymberknoh M, Lehavi M, Gileles-Hillel A et al (2023) Changes in sleep in children and adults with CF and primary ciliary dyskinesia over time and after CFTR modulator therapy. J Clin Med 12:7612","journal-title":"J Clin Med"},{"key":"7331_CR30","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0140-6736(24)01134-6","volume":"404","author":"I Sermet-Gaudelus","year":"2024","unstructured":"Sermet-Gaudelus I, Benaboud S, Bui S, Bihou\u00e9e T, Gautier S (2024) Behavioural and sleep issues after initiation of ETI in preschool-age children with CF. Lancet 404:117\u2013120","journal-title":"Lancet"},{"key":"7331_CR31","doi-asserted-by":"publisher","DOI":"10.1177\/17534666221086416","volume":"16","author":"C Daly","year":"2022","unstructured":"Daly C, Ruane P, O\u2019Reilly K et al (2022) Caregiver burden in cystic fibrosis: a systematic literature review. Ther Adv Respir Dis 16:17534666221086416","journal-title":"Ther Adv Respir Dis"},{"key":"7331_CR32","doi-asserted-by":"publisher","first-page":"e002522","DOI":"10.1136\/bmjresp-2024-002522","volume":"12","author":"SH Davies","year":"2025","unstructured":"Davies SH, Wade F, Fogg H, Walsh A, Southern KW (2025) Qualitative study exploring the views and perceptions of parents\/carers of young children with CF regarding the introduction of CFTR modulator therapy (The REVEAL study). BMJ Open Respir Res 12:e002522","journal-title":"BMJ Open Respir Res"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-026-07331-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-026-07331-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-026-07331-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T15:02:55Z","timestamp":1789225375000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-026-07331-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,11]]},"references-count":32,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["7331"],"URL":"https:\/\/doi.org\/10.1007\/s00431-026-07331-5","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,11]]},"assertion":[{"value":"25 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Ankara Bilkent City Hospital local ethics committee (TABED 2\u201326-2087) and conducted following the Declaration of Helsinki. Written informed consent was obtained from each patient and their parents before starting the modulators.","order":1,"name":"Ethics","label":"Statement of Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"651"}}